Duty D12-668, published by Directorate General of Health Services, Ministry of Health and Family Welfare [D12-668]

As at 7 September 2026. In force from 12 May 2022.

Record DIRE/2022/0825, published 12 May 2022. Synthetic record: the register composed these words to show what the department could publish. No department published them.

Cite: Duty DIRE/2022/0825, Directorate General of Health Services, Ministry of Health and Family Welfare [D12-668]. Machine: D12-668.

Addressee: Every manufacturer.

Required: Obtain a licence before undertaking the manufacture of drugs; apply in Form 25, fee five hundred rupees.

Period: Before the activity begins; licence valid three years.

Form: Form 25.

Source: Section 6, Assisted Reproductive Technology (Regulation) Act, 2021 [S2A-QSC].

Penalty provision: Section 54, Assisted Reproductive Technology (Regulation) Act, 2021 [S2A-S9M].

Published by: Directorate General of Health Services, Ministry of Health and Family Welfare.

In force: from 12 May 2022.